Cargando…

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?

INTRODUCTION: Rituximab (RTX) showed good efficacy and safety for patients with myasthenia gravis. However, the percentage of peripheral CD20+ B cell may be absent for years after low dose of RTX treatment. Persistent hypogammaglobulinemia and opportunistic infection may occur in patients under trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Jingru, Wang, Jianchun, Liu, Ran, Guo, Jing, Yao, Yan, Luo, Jingjing, Hao, Hongjun, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196171/ https://www.ncbi.nlm.nih.gov/pubmed/37213908 http://dx.doi.org/10.3389/fneur.2023.1152992

Ejemplares similares

Rituximab treatment in myasthenia gravis
por: Vesperinas-Castro, Ana, et al.
Publicado: (2023)

Thymoma and Myasthenia Gravis: An Examination of a Paraneoplastic Manifestation
por: Itani, Mira, et al.
Publicado: (2023)

Multiple Thymoma with Myasthenia Gravis
por: Seo, Dong Hyun, et al.
Publicado: (2017)

Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Rituximab in Refractory Myasthenia Gravis: Experience in a Single Healthcare Center in Mexico
por: López-Hernández, Juan Carlos, et al.
Publicado: (2021)

Thymoma-Associated Myasthenia Gravis With Myocarditis
por: Sarwar, Shihab, et al.
Publicado: (2023)

Immunoregulatory Cells in Myasthenia Gravis
por: Wu, Ying, et al.
Publicado: (2020)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Recurrent Opportunistic Infections in a Thymectomised Patient with Myasthenia Gravis and Good’s Syndrome
por: Shankar Kikkeri, Nidhi, et al.
Publicado: (2018)

Thymoma in Myasthenia Gravis: From Diagnosis to Treatment
por: Romi, Fredrik
Publicado: (2011)

Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report
por: Zhou, Zhijian, et al.
Publicado: (2019)

Effectiveness and Safety of Rituximab for Refractory Myasthenia Gravis: A Systematic Review and Single-Arm Meta-Analysis
por: Zhao, Cong, et al.
Publicado: (2021)

Novel Treatments in Myasthenia Gravis
por: Menon, Deepak, et al.
Publicado: (2020)

Management of Juvenile Myasthenia Gravis
por: O'Connell, Karen, et al.
Publicado: (2020)

Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020)

Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022)

Role of complement in myasthenia gravis
por: San, Pyae Phyo, et al.
Publicado: (2023)

Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis
por: Zheng, Yiming, et al.
Publicado: (2022)

Thymoma complicated with myasthenia gravis and Good syndrome – a therapeutic conundrum: a case report
por: Paranavitane, Shiran, et al.
Publicado: (2019)

Ectopic cervical thymoma in a patient with Myasthenia gravis
por: Wu, Ti Hei, et al.
Publicado: (2011)

Incidence of Thymoma in Myasthenia Gravis: A Systematic Review
por: Mao, Zhi-Feng, et al.
Publicado: (2012)

The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis
por: Xin, Yanzhong, et al.
Publicado: (2016)

Myasthenia gravis: Antigen presentation by thymoma epithelial cells
por: Gilhus, N.E., et al.
Publicado: (1994)

Surgical effect and prognostic factors of myasthenia gravis with thymomas
por: Tian, Wenxin, et al.
Publicado: (2020)

Immune-Related Molecular Profiling of Thymoma With Myasthenia Gravis
por: Zhuang, Jinman, et al.
Publicado: (2021)

Pathological Features and Prognosis of Thymoma With or Without Myasthenia Gravis
por: Zhang, Yunfeng, et al.
Publicado: (2022)

Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study
por: Li, Jinghao, et al.
Publicado: (2021)

Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis
por: Duan, Weiwei, et al.
Publicado: (2022)

Corticosteroid Treatment-Resistance in Myasthenia Gravis
por: Kaminski, Henry J., et al.
Publicado: (2022)

User Involvement in Myasthenia Gravis Research
por: Gilhus, Nils Erik, et al.
Publicado: (2022)

Myasthenia Gravis Presenting as Bulbar Palsy
por: Gosain, Dhruv, et al.
Publicado: (2023)

The LINC00452/miR-204/CHST4 Axis Regulating Thymic Tregs Might Be Involved in the Progression of Thymoma-Associated Myasthenia Gravis
por: Wang, Fuqiang, et al.
Publicado: (2022)

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

Risk factors for postoperative myasthenia gravis in patients with thymoma without myasthenia gravis: A systematic review and meta-analysis
por: Tang, Mingbo, et al.
Publicado: (2023)

Cerebral toxoplasmosis in a patient with myasthenia gravis and thymoma with immunodeficiency/Good’s syndrome: a case report
por: Sasson, Sarah C., et al.
Publicado: (2016)

Intrapericardial Thymoma Presented as Pericardial Tamponade with Post-Operative Myasthenia Gravis
por: Tsai, Yueh-Hsun, et al.
Publicado: (2022)

Vitamin D Receptor Polymorphism and Myasthenia Gravis in Chinese Han Population
por: Han, Ji-Lan, et al.
Publicado: (2021)

Treatment of insomnia in myasthenia gravis—A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia
por: Yan, Jingwen, et al.
Publicado: (2023)

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis
por: Monteleone, Jonathan P. R., et al.
Publicado: (2021)

cFLIP overexpression in T cells in thymoma-associated myasthenia gravis
por: Belharazem, Djeda, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7oevag165fs6bm98eff38cvbvq